» Articles » PMID: 27780008

Severe Hemophilia A in a Male Old English Sheep Dog with a C→T Transition That Created a Premature Stop Codon in Factor VIII

Overview
Journal Comp Med
Specialty General Medicine
Date 2016 Oct 26
PMID 27780008
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Animals with hemophilia are models for gene therapy, factor replacement, and inhibitor development in humans. We have actively sought dogs with severe hemophilia A that have novel factor VIII mutations unlike the previously described factor VIII intron 22 inversion. A male Old English Sheepdog with recurrent soft-tissue hemorrhage and hemarthrosis was diagnosed with severe hemophilia A (factor VIII activity less than 1% of normal). We purified genomic DNA from this dog and ruled out the common intron 22 inversion; we then sequenced all 26 exons. Comparing the results with the normal canine factor VIII sequence revealed a C→T transition in exon 12 of the factor VIII gene that created a premature stop codon at amino acid 577 in the A2 domain of the protein. In addition, 2 previously described polymorphisms that do not cause hemophilia were present at amino acids 909 and 1184. The hemophilia mutation creates a new TaqI site that facilitates rapid genotyping of affected offspring by PCR and restriction endonuclease analyses. This mutation is analogous to the previously described human factor VIII mutation at Arg583, which likewise is a CpG dinucleotide transition causing a premature stop codon in exon 12. Thus far, despite extensive treatment with factor VIII, this dog has not developed neutralizing antibodies ('inhibitors') to the protein. This novel mutation in a dog gives rise to severe hemophilia A analogous to a mutation seen in humans. This model will be useful for studies of the treatment of hemophilia.

Citing Articles

A SINE Insertion in Gene Leads to Severe Form of Hemophilia A in a Family of Rhodesian Ridgebacks.

Kehl A, Haug Haaland A, Langbein-Detsch I, Mueller E Genes (Basel). 2021; 12(2).

PMID: 33494213 PMC: 7909816. DOI: 10.3390/genes12020134.

References
1.
Nichols T, Hough C, Agerso H, Ezban M, Lillicrap D . Canine models of inherited bleeding disorders in the development of coagulation assays, novel protein replacement and gene therapies. J Thromb Haemost. 2016; 14(5):894-905. DOI: 10.1111/jth.13301. View

2.
Lozier J, Dutra A, Pak E, Zhou N, Zheng Z, Nichols T . The Chapel Hill hemophilia A dog colony exhibits a factor VIII gene inversion. Proc Natl Acad Sci U S A. 2002; 99(20):12991-6. PMC: 130574. DOI: 10.1073/pnas.192219599. View

3.
Lin H, Maeda N, SMITHIES O, Straight D, Stafford D . A coagulation factor IX-deficient mouse model for human hemophilia B. Blood. 1997; 90(10):3962-6. View

4.
Porada C, Sanada C, Long C, Wood J, Desai J, Frederick N . Clinical and molecular characterization of a re-established line of sheep exhibiting hemophilia A. J Thromb Haemost. 2009; 8(2):276-85. PMC: 2826196. DOI: 10.1111/j.1538-7836.2009.03697.x. View

5.
Timur A, Gurgey A, Aktuglu G, Kavakli K, Canatan D, Olek K . Molecular pathology of haemophilia A in Turkish patients: identification of 36 independent mutations. Haemophilia. 2001; 7(5):475-81. DOI: 10.1046/j.1365-2516.2001.00548.x. View